Tag Mankind Pharma

Mumbai, September 2, 2024: Mankind Pharma, one of India’s leading pharmaceutical companies has announced its entry into the topical analgesic market through its consumer business division. The company is introducing Nimulid Strong, a revolutionary gel and spray formulation specifically designed to address neck pain, a condition that significantly impacts overall body function.

Nimulid Strong boasts a unique selling proposition of containing 2X diclofenac concentration, promising faster relief for consumers suffering from neck pain. This strategic move is in alignment with Mankind Pharma’s commitment to expanding its consumer healthcare portfolio and addressing critical pain management needs.

The launch is accompanied by a compelling video campaign titled #GardanHilaateRaho that highlights the cultural significance of neck movements in Indian communication. The campaign, voiced in Hindi, intertwines the importance of unrestricted neck movement with the efficacy of Nimulid Strong in alleviating neck pain. Therefore, to address the problem, the brand came up with a powerful campaign of Nimulid Strong that focuses on “Kaam Chalate Raho, Gardan Hilaate Raho.”

The video narrative ingeniously connects various scenarios where neck movements play a crucial role in non-verbal communication, from expressing anger and love to showcasing progress and even celebrating national victories. It emphasises how Nimulid Strong, with its powerful 2X diclofenac formulation, ensures that neck pain doesn’t hinder these essential interactions.

Joy Chatterjee, Vice President, Sales and Marketing Head, Consumer Business Unit, Mankind Pharma Ltd, shared, “Our entry into the topical analgesic market with Nimulid Strong marks a pivotal moment for Mankind Pharma’s consumer business. By focusing on neck pain, which can severely hinder daily life, we aim to empower millions of Indians to live and communicate more freely. Our innovative 2X diclofenac formulation, paired with a resonant video campaign, showcases how integral neck movements are in daily interactions. The campaign’s message, ‘Gardan dard ka specialist’ (Specialist in neck pain), positions Nimulid Strong as the go-to solution for this specific, yet widespread problem.”

Nimulid Strong will be available in both gel and spray variants, offering consumers flexibility in application. The product is set to be distributed across pharmacies and modern trade outlets nationwide, supported by an extensive marketing campaign across various media platforms.

With the topical analgesic market in India valued at ₹1488 crore, according to IQVIA, Mankind Pharma’s launch of Nimulid Strong arrives at a pivotal moment. This strategic move aligns with the company’s commitment to delivering high-quality, affordable healthcare solutions. By focusing on specific pain management needs, Nimulid Strong represents a significant advancement in Mankind Pharma’s consumer healthcare segment, positioning the company to capture a substantial share of the expanding market through its established distribution network and strong brand reputation.

Mumbai, India, 31 July, 2024: Mankind Pharma ,India’s fourth largest pharmaceutical Company  announced its financial results for the first quarter ended 30^th June 2024. The information mentioned in this release is based on consolidated financial statements.

Q1 FY25 Performance Summary

• Revenue from Operations at INR 2,893 Cr, up by 12% YoY
•  Domestic revenue at INR 2,634 Cr, up 9% YoY; Exports at INR 259 Cr, up 62% YoY

• EBITDA margin of 7% with Adj. EBITDA^# margin of 25.2% and PAT margin of 18.8%
• Diluted EPS* of INR 4, up by 10% YoY (FV Re.1)

   Domestic Business

•  Domestic revenue grew 9% YoY and 9.8% YoY (ex-CH)*.
• Secondary sales growth of 10.5% vs 7% IPM growth (1.2x to IPM) supported by
  • strong volume growth of 9% vs 0.4% for IPM
  • out-performance in chronic therapies (1.3x to IPM Chronic)
• Growth partially impacted by
  • delayed season in anti-infectives
  • certain product withdrawals in Q1FY24: normalized from Q2
• Ranked 2¹ by volume with a market share of 1% in Q1FY25 vs 5.9% in Q1FY24.
• Consistently maintained #1 rank over last 7 years with prescription share of 3% in Q1FY25.
• Prescriber Penetration increased to 2% in Q1FY25 vs 82.7% in Q1FY24.

  Consumer Healthcare Business

•  Recovery in revenue with 32% QoQ increase in Q1FY25 supported by faster growth in Modern Trade, E-commerce and Q-Commerce channels.
• Consistently expanding from Pregnancy Care & Sexual Wellness to Consumer Wellness through the launch of Ova News, Nimulid, Rapid News
• Witnessed good traction in Ova News, which has the potential to grow as big as Prega
• Despite heightened competition, our focused campaigns led to sustained leadership positioning of our key brands in their respective

Exports

•  In Q1FY25, witnessed a growth of 62% YoY driven by increase in our base business, and new launches.
• During the quarter, we have launched 2 new products in US taking the total launched products to

Consolidated Profit & Loss Account

Segmental Revenue Break Up

New Delhi,: HealthOK, a 100% vegetarian multivitamin tablet from the house of Mankind Pharma, has joined hands with Bikanervala, (Multinational Indian Restaurant & Sweets Chain) to champion the health and wellness of vegetarians. With the collaboration, HealthOK tablets aspires to reinforce its positioning as a 100% vegetarian multivitamin brand.

Vegetarians generally have limited options, which at times, makes it challenging for them to meet the required nutrients of the body. To address the problem, the brand came up with a campaign video that relates between HealthOK and Bikanervala. Through the video, the brand worked towards creating awareness around the 100% vegetarian health supplement HealthOK provides. Just like Bikanervala is recognized as a 100% vegetarian Food Brand, in a similar way, consumers can rely on HealthOK for vegetarian multivitamins.

Speaking about the collaboration, Joy Chatterjee, Associate Vice President, Sales and Marketing Head, Mankind Pharma, said, “As per various studies, 39% Indians are vegetarians & they are at higher risk of vitamin deficiency*. We aim to amplify the brand’s ‘24 Hour Active Energy’ campaign & spread awareness that our HealthOK tablets are 100% vegetarian tablet, exclusively sourced from vegetarian ingredients. Partnering with Bikanervala is a strategic decision as both brands are vegetarian. With HealthOK, we are making it easy for people to stick to their vegetarian diets while receiving all the nutrients they need. This collaboration shows our commitment to help vegetarians adhere to their chosen healthy lifestyle .”

Commenting on the same, Sangeeta Goel, GM Marketing Bikanervala Pvt. Ltd., said, “We at Bikanervala are excited to collaborate with HealthOK to support the health and wellness of vegetarians. Our dedication to providing high-quality vegetarian food perfectly aligns with HealthOK’s mission to offer essential nutrients through their supplements. Together, we aim to make it easier for vegetarians to lead a healthy lifestyle.”

This joint effort emphasizes the commitment to supporting individuals in their journey towards healthier living. And in the process, it also empowers vegetarians to make informed choices that align with their dietary preferences and values.

Leading digital marketing agency, Social Beat, has secured the D2C digital mandate for Mankind Pharma, one of India’s leading pharmaceutical companies after a multi-agency pitch. The partnership with Social Beat will mark a significant step forward in Mankind Pharma’s digital marketing efforts to strengthen its online presence and engage with a wider audience.

Mankind Pharma, known for its commitment to providing high-quality healthcare solutions, has chosen Social Beat as its digital partner to drive sales through the brand’s own website and drive growth in the digital space. With a diverse portfolio of pharmaceutical products, Mankind Pharma aims to connect with consumers across various demographics and geographies.

“We are delighted to be chosen as the digital marketing partner for Mankind Pharma,” said Suneil Chawla, Co-founder of Social Beat. “This collaboration presents a fantastic opportunity to leverage our expertise in digital marketing to help Mankind Pharma reach new heights in the online landscape. We look forward to crafting a highly impactful website and campaigns that resonate with Mankind Pharma’s objectives and growth.”

Social Beat, known for its data-driven approach and creative digital solutions, has a track record of delivering outstanding results for a wide range of clients across industries. The agency will be responsible for crafting and executing comprehensive digital marketing strategies for Mankind Pharma, encompassing various channels such as social media, search engine optimization (SEO), content marketing, and more.

Speaking about the partnership, Mr Joy Chatterjee, AVP at Mankind Pharma, said, “In today’s digital age, it is imperative for us to have a strong online presence and engage effectively with our customers. Social Beat’s expertise in the digital marketing arena and their proven track record make them the ideal partner for our digital journey. We are excited about the opportunities this collaboration will bring and are confident that together, we will achieve great success.”

Social Beat’s experience in the pharmaceutical sector, coupled with its understanding of the Indian market, positions it well to assist Mankind Pharma in achieving its digital marketing objectives.